https://www.selleckchem.com/pr....oducts/daratumumab.h
Of 819 participants, 85 were classified as having autoimmune rheumatic diseases screened for by the adapted CSQ. The original CSQ scoring yielded relatively lower sensitivities in detecting both any and individual autoimmune rheumatic diseases (67% and 20-57%, respectively) compared to the modified CSQ scoring (81% and 60-73%, respectively) and the scoring based on current classification criteria (89% and 50-88%, respectively). The adapted CSQ with the classification criteria-based scoring achieved relatively high sensitivities in d
Like
Comment
Share
